These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10738565)

  • 1. Adeno-associated virus-mediated gene delivery.
    Snyder RO
    J Gene Med; 1999; 1(3):166-75. PubMed ID: 10738565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated viral vectors for gene transfer and gene therapy.
    Büeler H
    Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer by adeno-associated virus vectors into the central nervous system.
    Xiao X; Li J; McCown TJ; Samulski RJ
    Exp Neurol; 1997 Mar; 144(1):113-24. PubMed ID: 9126160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
    Małecki M; Swoboda P; Pachecka J
    Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV-directed muscular dystrophy gene therapy.
    Tang Y; Cummins J; Huard J; Wang B
    Expert Opin Biol Ther; 2010 Mar; 10(3):395-408. PubMed ID: 20132060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney.
    Kapturczak MH; Chen S; Agarwal A
    Acta Biochim Pol; 2005; 52(2):293-9. PubMed ID: 15940344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
    Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
    Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adeno-associated virus (rAAV) vectors for somatic gene therapy: recent advances and potential clinical applications.
    Hallek M; Wendtner CM
    Cytokines Mol Ther; 1996 Jun; 2(2):69-79. PubMed ID: 9384691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
    Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
    Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic gene therapy using adeno-associated virus vectors.
    Patijn GA; Kay MA
    Semin Liver Dis; 1999; 19(1):61-9. PubMed ID: 10349684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
    Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
    J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer to the gastrointestinal tract after peroral administration of recombinant adeno-associated virus type 2 vectors.
    Shao G; Greathouse K; Huang Q; Wang CM; Sferra TJ
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):168-79. PubMed ID: 16877980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
    Rolling F
    Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated viral vectors: background and technical aspects.
    Snoeck HW; Tao W; Klotman ME
    Exp Nephrol; 1997; 5(6):514-20. PubMed ID: 9438181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
    Couto LB
    Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.
    Le Bec C; Douar AM
    Gene Ther; 2006 May; 13(10):805-13. PubMed ID: 16453010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.